Literature DB >> 24500688

Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells.

Shaoxiong Wang1, Xi Lu, Jian Yang, Hongyong Wang, CaiYu Chen, Yu Han, Hongmei Ren, Shuo Zheng, Duofen He, Lin Zhou, Laureano D Asico, Wei Eric Wang, Pedro A Jose, Chunyu Zeng.   

Abstract

The dopaminergic and sympathetic systems interact to regulate blood pressure. Our previous studies showed regulation of α1-adrenergic receptor function by D1-like dopamine receptors in vascular smooth muscle cells. Because renalase could regulate circulating epinephrine levels and dopamine production in renal proximal tubules (RPTs), we tested the hypothesis that D1-like receptors regulate renalase expression in kidney. The effect of D1-like receptor stimulation on renalase expression and function was measured in immortalized RPT cells from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs). We found that the D1-like receptor agonist fenoldopam (10(-7)-10(-5) mol/l) increased renalase protein expression and function in WKY RPT cells but decreased them in SHR cells. Fenoldopam also increased renalase mRNA levels in WKY but not in SHR cells. In contrast, fenoldopam increased the degradation of renalase protein in SHR cells but not in WKY cells. The regulation of renalase by the D1-like receptor was mainly via the D5 receptor because silencing of the D5 but not D1 receptor by antisense oligonucleotides blocked the stimulatory effect of the D1-like receptor on renalase expression in WKY cells. Moreover, inhibition of PKC, by the PKC inhibitor 19-31, blocked the stimulatory effect of fenoldopam on renalase expression while stimulation of PKC, by a PKC agonist (PMA), increased renalase expression, indicating that PKC is involved in the process. Our studies suggest that the D5 receptor positively regulates renalase expression in WKY but not SHR RPT cells; aberrant regulation of renalase by the D5 receptor may be involved in the pathogenesis of hypertension.

Entities:  

Keywords:  dopamine receptor; hypertension; renal proximal tubule cells; renalase

Mesh:

Substances:

Year:  2014        PMID: 24500688      PMCID: PMC3949042          DOI: 10.1152/ajprenal.00196.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  49 in total

1.  Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha.

Authors:  Evangeline D Motley; Kunie Eguchi; Carla Gardner; Adrienne L Hicks; Cherilynn M Reynolds; Gerald D Frank; Mizuo Mifune; Motoi Ohba; Satoru Eguchi
Journal:  Hypertension       Date:  2003-01-13       Impact factor: 10.190

2.  Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression.

Authors:  Hironobu Sanada; Junichi Yatabe; Sanae Midorikawa; Tetsuo Katoh; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Jing Xu; Yingjin Luo; Xiaoyan Wang; Chunyu Zeng; Ines Armando; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2006-04-24       Impact factor: 10.190

3.  Decreased tubular uptake of L-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats.

Authors:  A Carranza; L Karabatas; M Barontini; I Armando
Journal:  Horm Res       Date:  2001

4.  Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive.

Authors:  Tom R Hollon; Martin J Bek; Jean E Lachowicz; Marjorie A Ariano; Eva Mezey; Ramesh Ramachandran; Scott R Wersinger; Patricio Soares-da-Silva; Zhi Fang Liu; Alexander Grinberg; John Drago; W Scott Young; Heiner Westphal; Pedro A Jose; David R Sibley
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

5.  Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron.

Authors:  Shaopeng Zheng; Peiying Yu; Chunyu Zeng; Zheng Wang; Zhiwei Yang; Peter M Andrews; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2003-02-24       Impact factor: 10.190

6.  Cardiovascular response to acute hypoxemia in adult rats hypoxemic neonatally.

Authors:  C V Rohlicek; T Matsuoka; C Saiki
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

7.  Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension.

Authors:  J Xu; X X Li; F E Albrecht; U Hopfer; R M Carey; P A Jose
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

8.  Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors.

Authors:  K Yasunari; M Kohno; H Kano; M Minami; J Yoshikawa
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

9.  G protein-coupled receptor kinase 4 gene variants in human essential hypertension.

Authors:  Robin A Felder; Hironobu Sanada; Jing Xu; Pei-Ying Yu; Zheng Wang; Hidetsuna Watanabe; Laureano D Asico; Wei Wang; Shaopeng Zheng; Ikuyo Yamaguchi; Scott M Williams; James Gainer; Nancy J Brown; Debra Hazen-Martin; Lee-Jun C Wong; Jean E Robillard; Robert M Carey; Gilbert M Eisner; Pedro A Jose
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

10.  In vivo effects of fenoldopam on autonomic nervous system after inhibition or activation of ganglionic transmission.

Authors:  Fabienne Vernejoul; Christine Damase-Michel; Jean-Louis Montastruc; Marie-Antoinette Tran
Journal:  Eur J Pharmacol       Date:  2002-05-31       Impact factor: 4.432

View more
  9 in total

1.  Plasma renalase concentration before and after radiofrequency renal denervation in patients with resistant hypertension.

Authors:  M T Wybraniec; B Czerwieńska; M Lelek; M Adamczak; A Więcek; K Mizia-Stec
Journal:  J Hum Hypertens       Date:  2015-08-27       Impact factor: 3.012

Review 2.  Antihypertensive mechanisms of intra-renal dopamine.

Authors:  Ming-Zhi Zhang; Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

Review 3.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

Review 4.  Renalase: its role as a cytokine, and an update on its association with type 1 diabetes and ischemic stroke.

Authors:  Xiaojia Guo; Ling Wang; Heino Velazquez; Robert Safirstein; Gary V Desir
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

Review 5.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

6.  Role of Thioredoxin 1 in Impaired Renal Sodium Excretion of hD 5 R F173L Transgenic Mice.

Authors:  Shaoxiong Wang; Xiaorong Tan; Peng Chen; Shuo Zheng; Hongmei Ren; Jin Cai; Lin Zhou; Pedro A Jose; Jian Yang; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

7.  Renalase in Haemodialysis Patients with Chronic Kidney Disease.

Authors:  Magda Wisniewska; Natalia Serwin; Violetta Dziedziejko; Małgorzata Marchelek-Mysliwiec; Barbara Dołegowska; Leszek Domanski; Kazimierz Ciechanowski; Krzysztof Safranow; Andrzej Pawlik
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

Review 8.  Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Juan Jesus Cruz-Hernandez; Rogelio González Sarmiento; Ricardo Usategui-Martin; José Pablo Miramontes-González
Journal:  Biomolecules       Date:  2021-02-10

9.  Associations of Renalase With Blood Pressure and Hypertension in Chinese Adults.

Authors:  Yang Wang; Chen Chen; Gui-Lin Hu; Chao Chu; Xiao-Yu Zhang; Ming-Fei Du; Ting Zou; Qing Zhou; Yue-Yuan Liao; Qiong Ma; Ke-Ke Wang; Yue Sun; Dan Wang; Yu Yan; Yan Li; Hao Jia; Ze-Jiaxin Niu; Xi Zhang; Lan Wang; Zi-Yue Man; Wei-Hua Gao; Chun-Hua Li; Jie Zhang; Ke Gao; Hui-Xian Li; John Chang; Gary V Desir; Wan-Hong Lu; Jian-Jun Mu
Journal:  Front Cardiovasc Med       Date:  2022-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.